Eman Alefishat
Effects of NAD at purine receptors in isolated blood vessels
Alefishat, Eman; Alexander, Stephen P.H.; Ralevic, Vera
Authors
Stephen P.H. Alexander
Dr VERA RALEVIC vera.ralevic@nottingham.ac.uk
ASSOCIATE PROFESSOR & READER IN CARDIOVASCULAR SCIENCES
Abstract
Nicotinamide adenine dinucleotide (NAD) belongs to the family of naturally occurring adenine dinucleotides, best known for their various intracellular roles. However, there is evidence that they can also be released from cells to act as novel extracellular signalling molecules. Relatively little is known about the extracellular actions of NAD, especially in the cardiovascular system. The present study investigated the actions of NAD in the rat thoracic aorta, porcine coronary artery and porcine mesenteric arteries, mounted in organ baths for isometric tension recording. In the rat thoracic aorta and porcine coronary artery, NAD caused endothelium-independent concentration-dependent vasorelaxations which were unaffected by palmitoylCoA, a P2Y1 receptor antagonist, but which were blocked by CGS15943, a non-selective adenosine receptor antagonist. In the porcine coronary artery, NAD-evoked relaxations were abolished by SCH58261, a selective A2A receptor antagonist. In the rat thoracic aorta, NAD-evoked relaxations were attenuated by A2A receptor antagonism with SCH58261 but were unaffected by an A2B receptor antagonist, MRS1754. In contrast, in the porcine mesenteric artery, NAD-evoked endothelium-independent contractions, which were unaffected by a P2 receptor antagonist, suramin, or by NF449, a P2X1 receptor antagonist, but were attenuated following P2X receptor desensitisation with αβ-meATP. In conclusion, the present results show that NAD can alter vascular tone through actions at purine receptors in three different arteries from two species; its molecular targets differ according to the type of blood vessel.
Citation
Alefishat, E., Alexander, S. P., & Ralevic, V. (2015). Effects of NAD at purine receptors in isolated blood vessels. Purinergic Signalling, 11(1), https://doi.org/10.1007/s11302-014-9428-1
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 23, 2014 |
Online Publication Date | Oct 15, 2014 |
Publication Date | Mar 1, 2015 |
Deposit Date | Jul 11, 2016 |
Publicly Available Date | Jul 11, 2016 |
Journal | Purinergic Signalling |
Print ISSN | 1573-9538 |
Electronic ISSN | 1573-9546 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 11 |
Issue | 1 |
DOI | https://doi.org/10.1007/s11302-014-9428-1 |
Keywords | NAD, P2 purine receptors, adenosine receptors, artery, vasorelaxation |
Public URL | https://nottingham-repository.worktribe.com/output/743920 |
Publisher URL | http://link.springer.com/article/10.1007%2Fs11302-014-9428-1 |
Contract Date | Jul 11, 2016 |
Files
NAD paper final v4 revised-all.pdf
(1.8 Mb)
PDF
You might also like
Natural product pharmacology: the British Journal of Pharmacology perspective
(2024)
Journal Article
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review
(2024)
Journal Article
The IUPHAR/BPS Guide to PHARMACOLOGY in 2024
(2023)
Journal Article
Looking Under the Lamppost: The Search for New Cancer Targets in the Human Kinome
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search